nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—BCHE—Triamcinolone—hematologic cancer	0.109	0.421	CbGbCtD
Procaine—BCHE—Irinotecan—hematologic cancer	0.0826	0.319	CbGbCtD
Procaine—BCHE—Cisplatin—hematologic cancer	0.0673	0.26	CbGbCtD
Procaine—SCN10A—hematopoietic system—hematologic cancer	0.00448	0.0984	CbGeAlD
Procaine—GRIN3A—testis—hematologic cancer	0.00434	0.0954	CbGeAlD
Procaine—HTR3A—hematopoietic system—hematologic cancer	0.00415	0.0912	CbGeAlD
Procaine—CHRNA2—blood—hematologic cancer	0.00385	0.0846	CbGeAlD
Procaine—SLC6A3—hematopoietic system—hematologic cancer	0.00346	0.0759	CbGeAlD
Procaine—SCN10A—blood—hematologic cancer	0.00297	0.0652	CbGeAlD
Procaine—HTR3A—blood—hematologic cancer	0.00275	0.0605	CbGeAlD
Procaine—SCN10A—lung—hematologic cancer	0.0026	0.0572	CbGeAlD
Procaine—HTR3A—lung—hematologic cancer	0.00241	0.053	CbGeAlD
Procaine—BCHE—hematopoietic system—hematologic cancer	0.0023	0.0506	CbGeAlD
Procaine—SLC6A3—lung—hematologic cancer	0.00201	0.0441	CbGeAlD
Procaine—SLC6A3—testis—hematologic cancer	0.00189	0.0416	CbGeAlD
Procaine—SCN10A—lymph node—hematologic cancer	0.00178	0.0391	CbGeAlD
Procaine—Probenecid—ABCC3—hematologic cancer	0.00177	0.221	CrCbGaD
Procaine—BCHE—blood—hematologic cancer	0.00153	0.0335	CbGeAlD
Procaine—BCHE—bone marrow—hematologic cancer	0.00148	0.0325	CbGeAlD
Procaine—BCHE—lung—hematologic cancer	0.00134	0.0294	CbGeAlD
Procaine—BCHE—testis—hematologic cancer	0.00126	0.0277	CbGeAlD
Procaine—Probenecid—SLC22A1—hematologic cancer	0.00123	0.153	CrCbGaD
Procaine—Aminohippurate—SLC22A1—hematologic cancer	0.00121	0.151	CrCbGaD
Procaine—Clomifene—ESR1—hematologic cancer	0.000948	0.118	CrCbGaD
Procaine—Procainamide—SLC22A1—hematologic cancer	0.000946	0.118	CrCbGaD
Procaine—BCHE—lymph node—hematologic cancer	0.000916	0.0201	CbGeAlD
Procaine—Benzocaine—ABCB1—hematologic cancer	0.000422	0.0526	CrCbGaD
Procaine—Clomifene—ABCB1—hematologic cancer	0.000403	0.0502	CrCbGaD
Procaine—Probenecid—ALB—hematologic cancer	0.000375	0.0468	CrCbGaD
Procaine—Probenecid—ABCB1—hematologic cancer	0.000358	0.0446	CrCbGaD
Procaine—Aminohippurate—ABCB1—hematologic cancer	0.000353	0.044	CrCbGaD
Procaine—Erythema—Prednisone—hematologic cancer	0.0002	0.000332	CcSEcCtD
Procaine—Rash—Thiotepa—hematologic cancer	0.000199	0.000332	CcSEcCtD
Procaine—Dermatitis—Thiotepa—hematologic cancer	0.000199	0.000332	CcSEcCtD
Procaine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000199	0.000332	CcSEcCtD
Procaine—Diarrhoea—Alitretinoin—hematologic cancer	0.000199	0.000332	CcSEcCtD
Procaine—Convulsion—Betamethasone—hematologic cancer	0.000199	0.00033	CcSEcCtD
Procaine—Convulsion—Dexamethasone—hematologic cancer	0.000199	0.00033	CcSEcCtD
Procaine—Hypertension—Dexamethasone—hematologic cancer	0.000198	0.000329	CcSEcCtD
Procaine—Hypertension—Betamethasone—hematologic cancer	0.000198	0.000329	CcSEcCtD
Procaine—Diarrhoea—Ifosfamide—hematologic cancer	0.000197	0.000328	CcSEcCtD
Procaine—Nausea—Vinorelbine—hematologic cancer	0.000197	0.000327	CcSEcCtD
Procaine—Body temperature increased—Cisplatin—hematologic cancer	0.000196	0.000326	CcSEcCtD
Procaine—Fatigue—Etoposide—hematologic cancer	0.000196	0.000326	CcSEcCtD
Procaine—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000196	0.000326	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000195	0.00225	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NCOA3—hematologic cancer	0.000195	0.00225	CbGpPWpGaD
Procaine—Vomiting—Thalidomide—hematologic cancer	0.000195	0.000324	CcSEcCtD
Procaine—Anxiety—Betamethasone—hematologic cancer	0.000194	0.000324	CcSEcCtD
Procaine—Anxiety—Dexamethasone—hematologic cancer	0.000194	0.000324	CcSEcCtD
Procaine—Dizziness—Carmustine—hematologic cancer	0.000194	0.000323	CcSEcCtD
Procaine—SCN10A—L1CAM interactions—SRC—hematologic cancer	0.000194	0.00224	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000194	0.00224	CbGpPWpGaD
Procaine—Rash—Thalidomide—hematologic cancer	0.000193	0.000321	CcSEcCtD
Procaine—Dermatitis—Thalidomide—hematologic cancer	0.000193	0.000321	CcSEcCtD
Procaine—Dizziness—Alitretinoin—hematologic cancer	0.000193	0.00032	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.000192	0.00222	CbGpPWpGaD
Procaine—Diarrhoea—Vincristine—hematologic cancer	0.000192	0.000319	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000191	0.00221	CbGpPWpGaD
Procaine—Dizziness—Ifosfamide—hematologic cancer	0.00019	0.000317	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.00019	0.00219	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NCAM1—hematologic cancer	0.00019	0.00219	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000189	0.00218	CbGpPWpGaD
Procaine—Pruritus—Gemcitabine—hematologic cancer	0.000188	0.000313	CcSEcCtD
Procaine—Vision blurred—Prednisone—hematologic cancer	0.000188	0.000313	CcSEcCtD
Procaine—Nausea—Thiotepa—hematologic cancer	0.000188	0.000313	CcSEcCtD
Procaine—SLC6A3—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000188	0.00217	CbGpPWpGaD
Procaine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000188	0.000313	CcSEcCtD
Procaine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000187	0.000311	CcSEcCtD
Procaine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000187	0.000311	CcSEcCtD
Procaine—Oedema—Dexamethasone—hematologic cancer	0.000187	0.000311	CcSEcCtD
Procaine—Oedema—Betamethasone—hematologic cancer	0.000187	0.000311	CcSEcCtD
Procaine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000187	0.000311	CcSEcCtD
Procaine—Diarrhoea—Irinotecan—hematologic cancer	0.000187	0.000311	CcSEcCtD
Procaine—Vomiting—Carmustine—hematologic cancer	0.000187	0.000311	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—NQO1—hematologic cancer	0.000186	0.00214	CbGpPWpGaD
Procaine—Dizziness—Vincristine—hematologic cancer	0.000185	0.000309	CcSEcCtD
Procaine—Rash—Carmustine—hematologic cancer	0.000185	0.000308	CcSEcCtD
Procaine—Dermatitis—Carmustine—hematologic cancer	0.000185	0.000308	CcSEcCtD
Procaine—Vomiting—Alitretinoin—hematologic cancer	0.000185	0.000308	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—hematologic cancer	0.000185	0.000308	CcSEcCtD
Procaine—Shock—Betamethasone—hematologic cancer	0.000184	0.000306	CcSEcCtD
Procaine—Shock—Dexamethasone—hematologic cancer	0.000184	0.000306	CcSEcCtD
Procaine—Rash—Alitretinoin—hematologic cancer	0.000184	0.000305	CcSEcCtD
Procaine—Agitation—Prednisone—hematologic cancer	0.000183	0.000305	CcSEcCtD
Procaine—Dermatitis—Alitretinoin—hematologic cancer	0.000183	0.000305	CcSEcCtD
Procaine—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000183	0.000305	CcSEcCtD
Procaine—Thrombocytopenia—Betamethasone—hematologic cancer	0.000183	0.000305	CcSEcCtD
Procaine—Vomiting—Ifosfamide—hematologic cancer	0.000183	0.000304	CcSEcCtD
Procaine—Hypersensitivity—Cisplatin—hematologic cancer	0.000183	0.000304	CcSEcCtD
Procaine—Tachycardia—Dexamethasone—hematologic cancer	0.000183	0.000304	CcSEcCtD
Procaine—Tachycardia—Betamethasone—hematologic cancer	0.000183	0.000304	CcSEcCtD
Procaine—Bradycardia—Epirubicin—hematologic cancer	0.000183	0.000304	CcSEcCtD
Procaine—SLC6A3—Monoamine Transport—TNF—hematologic cancer	0.000182	0.0021	CbGpPWpGaD
Procaine—Angioedema—Prednisone—hematologic cancer	0.000182	0.000303	CcSEcCtD
Procaine—Diarrhoea—Gemcitabine—hematologic cancer	0.000182	0.000303	CcSEcCtD
Procaine—Nausea—Thalidomide—hematologic cancer	0.000182	0.000302	CcSEcCtD
Procaine—Rash—Ifosfamide—hematologic cancer	0.000181	0.000302	CcSEcCtD
Procaine—Dermatitis—Ifosfamide—hematologic cancer	0.000181	0.000302	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—hematologic cancer	0.000181	0.000301	CcSEcCtD
Procaine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000181	0.000301	CcSEcCtD
Procaine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000181	0.000301	CcSEcCtD
Procaine—Dizziness—Irinotecan—hematologic cancer	0.000181	0.000301	CcSEcCtD
Procaine—Urticaria—Etoposide—hematologic cancer	0.000181	0.0003	CcSEcCtD
Procaine—Body temperature increased—Etoposide—hematologic cancer	0.00018	0.000299	CcSEcCtD
Procaine—SCN10A—Developmental Biology—CTNNA1—hematologic cancer	0.000179	0.00207	CbGpPWpGaD
Procaine—Syncope—Prednisone—hematologic cancer	0.000179	0.000298	CcSEcCtD
Procaine—SCN10A—L1CAM interactions—MAPK3—hematologic cancer	0.000179	0.00206	CbGpPWpGaD
Procaine—Tinnitus—Methotrexate—hematologic cancer	0.000179	0.000297	CcSEcCtD
Procaine—Vomiting—Vincristine—hematologic cancer	0.000178	0.000297	CcSEcCtD
Procaine—SCN10A—Axon guidance—GRB2—hematologic cancer	0.000178	0.00205	CbGpPWpGaD
Procaine—Urticaria—Prednisolone—hematologic cancer	0.000178	0.000296	CcSEcCtD
Procaine—Fatigue—Triamcinolone—hematologic cancer	0.000178	0.000296	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000178	0.00205	CbGpPWpGaD
Procaine—Rash—Vincristine—hematologic cancer	0.000177	0.000294	CcSEcCtD
Procaine—Dermatitis—Vincristine—hematologic cancer	0.000177	0.000294	CcSEcCtD
Procaine—Loss of consciousness—Prednisone—hematologic cancer	0.000175	0.000292	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—CTSZ—hematologic cancer	0.000175	0.00202	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ANPEP—hematologic cancer	0.000175	0.00202	CbGpPWpGaD
Procaine—Hypotension—Dexamethasone—hematologic cancer	0.000175	0.000291	CcSEcCtD
Procaine—Hypotension—Betamethasone—hematologic cancer	0.000175	0.000291	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—HSP90AA1—hematologic cancer	0.000175	0.00201	CbGpPWpGaD
Procaine—Nausea—Carmustine—hematologic cancer	0.000175	0.000291	CcSEcCtD
Procaine—Vomiting—Irinotecan—hematologic cancer	0.000174	0.000289	CcSEcCtD
Procaine—Vomiting—Mitoxantrone—hematologic cancer	0.000174	0.000289	CcSEcCtD
Procaine—Nausea—Alitretinoin—hematologic cancer	0.000173	0.000288	CcSEcCtD
Procaine—Convulsion—Prednisone—hematologic cancer	0.000173	0.000288	CcSEcCtD
Procaine—Hypertension—Prednisone—hematologic cancer	0.000172	0.000287	CcSEcCtD
Procaine—Rash—Mitoxantrone—hematologic cancer	0.000172	0.000287	CcSEcCtD
Procaine—Rash—Irinotecan—hematologic cancer	0.000172	0.000287	CcSEcCtD
Procaine—Dermatitis—Irinotecan—hematologic cancer	0.000172	0.000286	CcSEcCtD
Procaine—Dermatitis—Mitoxantrone—hematologic cancer	0.000172	0.000286	CcSEcCtD
Procaine—Chills—Methotrexate—hematologic cancer	0.000172	0.000286	CcSEcCtD
Procaine—SCN10A—Axon guidance—ABL1—hematologic cancer	0.000171	0.00197	CbGpPWpGaD
Procaine—Nausea—Ifosfamide—hematologic cancer	0.000171	0.000284	CcSEcCtD
Procaine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.00017	0.000284	CcSEcCtD
Procaine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.00017	0.000284	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.00017	0.00196	CbGpPWpGaD
Procaine—Arthralgia—Prednisone—hematologic cancer	0.00017	0.000283	CcSEcCtD
Procaine—Diarrhoea—Cisplatin—hematologic cancer	0.00017	0.000282	CcSEcCtD
Procaine—Anxiety—Prednisone—hematologic cancer	0.000169	0.000282	CcSEcCtD
Procaine—Vomiting—Gemcitabine—hematologic cancer	0.000169	0.000282	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—hematologic cancer	0.000169	0.000281	CcSEcCtD
Procaine—Rash—Gemcitabine—hematologic cancer	0.000168	0.000279	CcSEcCtD
Procaine—Dermatitis—Gemcitabine—hematologic cancer	0.000168	0.000279	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000168	0.00193	CbGpPWpGaD
Procaine—Hypersensitivity—Etoposide—hematologic cancer	0.000167	0.000279	CcSEcCtD
Procaine—Tinnitus—Epirubicin—hematologic cancer	0.000167	0.000278	CcSEcCtD
Procaine—SLC6A3—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000167	0.00193	CbGpPWpGaD
Procaine—Erythema—Methotrexate—hematologic cancer	0.000167	0.000278	CcSEcCtD
Procaine—Nausea—Vincristine—hematologic cancer	0.000167	0.000277	CcSEcCtD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000166	0.00192	CbGpPWpGaD
Procaine—Hypersensitivity—Prednisolone—hematologic cancer	0.000165	0.000275	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—DPM1—hematologic cancer	0.000165	0.0019	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ASNS—hematologic cancer	0.000165	0.0019	CbGpPWpGaD
Procaine—Urticaria—Triamcinolone—hematologic cancer	0.000164	0.000273	CcSEcCtD
Procaine—Body temperature increased—Triamcinolone—hematologic cancer	0.000163	0.000271	CcSEcCtD
Procaine—Anaphylactic shock—Prednisone—hematologic cancer	0.000163	0.000271	CcSEcCtD
Procaine—Oedema—Prednisone—hematologic cancer	0.000163	0.000271	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000163	0.00188	CbGpPWpGaD
Procaine—Nausea—Mitoxantrone—hematologic cancer	0.000162	0.00027	CcSEcCtD
Procaine—Nausea—Irinotecan—hematologic cancer	0.000162	0.00027	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000162	0.00186	CbGpPWpGaD
Procaine—Fatigue—Betamethasone—hematologic cancer	0.000161	0.000268	CcSEcCtD
Procaine—Fatigue—Dexamethasone—hematologic cancer	0.000161	0.000268	CcSEcCtD
Procaine—SCN10A—Developmental Biology—PTPRC—hematologic cancer	0.000161	0.00186	CbGpPWpGaD
Procaine—Chills—Epirubicin—hematologic cancer	0.000161	0.000268	CcSEcCtD
Procaine—Pruritus—Etoposide—hematologic cancer	0.000161	0.000268	CcSEcCtD
Procaine—Shock—Prednisone—hematologic cancer	0.00016	0.000267	CcSEcCtD
Procaine—BCHE—Neuronal System—SLC22A1—hematologic cancer	0.00016	0.00184	CbGpPWpGaD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000159	0.00183	CbGpPWpGaD
Procaine—Tachycardia—Prednisone—hematologic cancer	0.000159	0.000265	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000158	0.00183	CbGpPWpGaD
Procaine—Nausea—Gemcitabine—hematologic cancer	0.000158	0.000263	CcSEcCtD
Procaine—Vomiting—Cisplatin—hematologic cancer	0.000158	0.000262	CcSEcCtD
Procaine—Hyperhidrosis—Prednisone—hematologic cancer	0.000157	0.000262	CcSEcCtD
Procaine—Vision blurred—Methotrexate—hematologic cancer	0.000157	0.000262	CcSEcCtD
Procaine—SLC6A3—Neuronal System—SLC22A1—hematologic cancer	0.000157	0.00181	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000157	0.00181	CbGpPWpGaD
Procaine—Rash—Cisplatin—hematologic cancer	0.000156	0.00026	CcSEcCtD
Procaine—Dermatitis—Cisplatin—hematologic cancer	0.000156	0.00026	CcSEcCtD
Procaine—Erythema—Epirubicin—hematologic cancer	0.000156	0.00026	CcSEcCtD
Procaine—Diarrhoea—Etoposide—hematologic cancer	0.000155	0.000259	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—GSTP1—hematologic cancer	0.000155	0.00179	CbGpPWpGaD
Procaine—Tinnitus—Doxorubicin—hematologic cancer	0.000155	0.000257	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000154	0.00178	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—JAK1—hematologic cancer	0.000154	0.00177	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000154	0.00177	CbGpPWpGaD
Procaine—Tension—Epirubicin—hematologic cancer	0.000153	0.000255	CcSEcCtD
Procaine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000152	0.000253	CcSEcCtD
Procaine—Nervousness—Epirubicin—hematologic cancer	0.000152	0.000252	CcSEcCtD
Procaine—SLC6A3—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000151	0.00174	CbGpPWpGaD
Procaine—Dizziness—Etoposide—hematologic cancer	0.00015	0.00025	CcSEcCtD
Procaine—CHRNA2—Neuronal System—PRKCG—hematologic cancer	0.000149	0.00172	CbGpPWpGaD
Procaine—Leukopenia—Methotrexate—hematologic cancer	0.000149	0.000248	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL1B—hematologic cancer	0.000149	0.00172	CbGpPWpGaD
Procaine—Chills—Doxorubicin—hematologic cancer	0.000149	0.000248	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—PREB—hematologic cancer	0.000149	0.00172	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—CASP3—hematologic cancer	0.000149	0.00171	CbGpPWpGaD
Procaine—Urticaria—Dexamethasone—hematologic cancer	0.000149	0.000247	CcSEcCtD
Procaine—Urticaria—Betamethasone—hematologic cancer	0.000149	0.000247	CcSEcCtD
Procaine—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000148	0.000247	CcSEcCtD
Procaine—Dizziness—Prednisolone—hematologic cancer	0.000148	0.000247	CcSEcCtD
Procaine—Body temperature increased—Dexamethasone—hematologic cancer	0.000148	0.000246	CcSEcCtD
Procaine—Body temperature increased—Betamethasone—hematologic cancer	0.000148	0.000246	CcSEcCtD
Procaine—Nausea—Cisplatin—hematologic cancer	0.000147	0.000245	CcSEcCtD
Procaine—Vision blurred—Epirubicin—hematologic cancer	0.000147	0.000245	CcSEcCtD
Procaine—BCHE—Neuronal System—ADCY7—hematologic cancer	0.000147	0.00169	CbGpPWpGaD
Procaine—Pruritus—Triamcinolone—hematologic cancer	0.000146	0.000243	CcSEcCtD
Procaine—Convulsion—Methotrexate—hematologic cancer	0.000144	0.00024	CcSEcCtD
Procaine—Vomiting—Etoposide—hematologic cancer	0.000144	0.00024	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000144	0.00167	CbGpPWpGaD
Procaine—Erythema—Doxorubicin—hematologic cancer	0.000144	0.00024	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—JUN—hematologic cancer	0.000144	0.00166	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—ADCY7—hematologic cancer	0.000144	0.00166	CbGpPWpGaD
Procaine—Agitation—Epirubicin—hematologic cancer	0.000143	0.000239	CcSEcCtD
Procaine—Rash—Etoposide—hematologic cancer	0.000143	0.000238	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000143	0.00165	CbGpPWpGaD
Procaine—Dermatitis—Etoposide—hematologic cancer	0.000143	0.000238	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—GCNT1—hematologic cancer	0.000143	0.00165	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000143	0.00164	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GSTM1—hematologic cancer	0.000142	0.00164	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—HGF—hematologic cancer	0.000142	0.00164	CbGpPWpGaD
Procaine—Arthralgia—Methotrexate—hematologic cancer	0.000142	0.000236	CcSEcCtD
Procaine—Tension—Doxorubicin—hematologic cancer	0.000142	0.000236	CcSEcCtD
Procaine—Rash—Prednisolone—hematologic cancer	0.000141	0.000235	CcSEcCtD
Procaine—Dermatitis—Prednisolone—hematologic cancer	0.000141	0.000235	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000141	0.00163	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—HSP90AA1—hematologic cancer	0.000141	0.00163	CbGpPWpGaD
Procaine—Fatigue—Prednisone—hematologic cancer	0.00014	0.000234	CcSEcCtD
Procaine—Nervousness—Doxorubicin—hematologic cancer	0.00014	0.000233	CcSEcCtD
Procaine—Syncope—Epirubicin—hematologic cancer	0.00014	0.000233	CcSEcCtD
Procaine—Leukopenia—Epirubicin—hematologic cancer	0.00014	0.000233	CcSEcCtD
Procaine—Loss of consciousness—Epirubicin—hematologic cancer	0.000137	0.000228	CcSEcCtD
Procaine—Dizziness—Triamcinolone—hematologic cancer	0.000136	0.000227	CcSEcCtD
Procaine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000136	0.000227	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—hematologic cancer	0.000136	0.000227	CcSEcCtD
Procaine—Convulsion—Epirubicin—hematologic cancer	0.000135	0.000225	CcSEcCtD
Procaine—Nausea—Etoposide—hematologic cancer	0.000135	0.000225	CcSEcCtD
Procaine—Hypertension—Epirubicin—hematologic cancer	0.000135	0.000224	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000135	0.00155	CbGpPWpGaD
Procaine—Thrombocytopenia—Methotrexate—hematologic cancer	0.000133	0.000222	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—EP300—hematologic cancer	0.000133	0.00154	CbGpPWpGaD
Procaine—Nausea—Prednisolone—hematologic cancer	0.000133	0.000222	CcSEcCtD
Procaine—Arthralgia—Epirubicin—hematologic cancer	0.000133	0.000221	CcSEcCtD
Procaine—Agitation—Doxorubicin—hematologic cancer	0.000133	0.000221	CcSEcCtD
Procaine—Anxiety—Epirubicin—hematologic cancer	0.000132	0.00022	CcSEcCtD
Procaine—Pruritus—Dexamethasone—hematologic cancer	0.000132	0.00022	CcSEcCtD
Procaine—Pruritus—Betamethasone—hematologic cancer	0.000132	0.00022	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000132	0.000219	CcSEcCtD
Procaine—Vomiting—Triamcinolone—hematologic cancer	0.000131	0.000218	CcSEcCtD
Procaine—BCHE—Neuronal System—CAMK2D—hematologic cancer	0.00013	0.0015	CbGpPWpGaD
Procaine—Rash—Triamcinolone—hematologic cancer	0.00013	0.000216	CcSEcCtD
Procaine—Dermatitis—Triamcinolone—hematologic cancer	0.00013	0.000216	CcSEcCtD
Procaine—Syncope—Doxorubicin—hematologic cancer	0.00013	0.000216	CcSEcCtD
Procaine—Urticaria—Prednisone—hematologic cancer	0.000129	0.000215	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—hematologic cancer	0.000129	0.000215	CcSEcCtD
Procaine—Body temperature increased—Prednisone—hematologic cancer	0.000129	0.000214	CcSEcCtD
Procaine—SLC6A3—Neuronal System—CAMK2D—hematologic cancer	0.000128	0.00148	CbGpPWpGaD
Procaine—Diarrhoea—Betamethasone—hematologic cancer	0.000128	0.000213	CcSEcCtD
Procaine—Diarrhoea—Dexamethasone—hematologic cancer	0.000128	0.000213	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000128	0.00147	CbGpPWpGaD
Procaine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000127	0.000212	CcSEcCtD
Procaine—Oedema—Epirubicin—hematologic cancer	0.000127	0.000212	CcSEcCtD
Procaine—Hypotension—Methotrexate—hematologic cancer	0.000127	0.000212	CcSEcCtD
Procaine—SCN10A—Developmental Biology—GRB2—hematologic cancer	0.000127	0.00147	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MET—hematologic cancer	0.000127	0.00146	CbGpPWpGaD
Procaine—Loss of consciousness—Doxorubicin—hematologic cancer	0.000127	0.000211	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000126	0.00145	CbGpPWpGaD
Procaine—Shock—Epirubicin—hematologic cancer	0.000125	0.000209	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000125	0.00144	CbGpPWpGaD
Procaine—Convulsion—Doxorubicin—hematologic cancer	0.000125	0.000208	CcSEcCtD
Procaine—Thrombocytopenia—Epirubicin—hematologic cancer	0.000125	0.000208	CcSEcCtD
Procaine—Hypertension—Doxorubicin—hematologic cancer	0.000125	0.000208	CcSEcCtD
Procaine—Tachycardia—Epirubicin—hematologic cancer	0.000124	0.000207	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000124	0.000206	CcSEcCtD
Procaine—Dizziness—Betamethasone—hematologic cancer	0.000124	0.000206	CcSEcCtD
Procaine—Dizziness—Dexamethasone—hematologic cancer	0.000124	0.000206	CcSEcCtD
Procaine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000123	0.000205	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—hematologic cancer	0.000123	0.000205	CcSEcCtD
Procaine—Anxiety—Doxorubicin—hematologic cancer	0.000123	0.000204	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—PDGFB—hematologic cancer	0.000122	0.00141	CbGpPWpGaD
Procaine—Nausea—Triamcinolone—hematologic cancer	0.000122	0.000204	CcSEcCtD
Procaine—SCN10A—Developmental Biology—ABL1—hematologic cancer	0.000122	0.00141	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MUC1—hematologic cancer	0.000121	0.0014	CbGpPWpGaD
Procaine—Somnolence—Methotrexate—hematologic cancer	0.000121	0.000201	CcSEcCtD
Procaine—Hypersensitivity—Prednisone—hematologic cancer	0.00012	0.0002	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.00012	0.00138	CbGpPWpGaD
Procaine—Hypotension—Epirubicin—hematologic cancer	0.000119	0.000198	CcSEcCtD
Procaine—Vomiting—Dexamethasone—hematologic cancer	0.000119	0.000198	CcSEcCtD
Procaine—Vomiting—Betamethasone—hematologic cancer	0.000119	0.000198	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000118	0.00137	CbGpPWpGaD
Procaine—Rash—Dexamethasone—hematologic cancer	0.000118	0.000196	CcSEcCtD
Procaine—Rash—Betamethasone—hematologic cancer	0.000118	0.000196	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000118	0.000196	CcSEcCtD
Procaine—Oedema—Doxorubicin—hematologic cancer	0.000118	0.000196	CcSEcCtD
Procaine—Dermatitis—Dexamethasone—hematologic cancer	0.000118	0.000196	CcSEcCtD
Procaine—Dermatitis—Betamethasone—hematologic cancer	0.000118	0.000196	CcSEcCtD
Procaine—SCN10A—Axon guidance—PTPN11—hematologic cancer	0.000117	0.00135	CbGpPWpGaD
Procaine—Fatigue—Methotrexate—hematologic cancer	0.000117	0.000195	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000117	0.00135	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000117	0.00135	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000117	0.00135	CbGpPWpGaD
Procaine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000116	0.000193	CcSEcCtD
Procaine—Shock—Doxorubicin—hematologic cancer	0.000116	0.000193	CcSEcCtD
Procaine—SCN10A—Developmental Biology—HES1—hematologic cancer	0.000116	0.00133	CbGpPWpGaD
Procaine—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000115	0.000192	CcSEcCtD
Procaine—Pruritus—Prednisone—hematologic cancer	0.000115	0.000192	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—hematologic cancer	0.000115	0.000191	CcSEcCtD
Procaine—SCN10A—Developmental Biology—NCOR1—hematologic cancer	0.000115	0.00132	CbGpPWpGaD
Procaine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000114	0.00019	CcSEcCtD
Procaine—SCN10A—Axon guidance—CREB1—hematologic cancer	0.000114	0.00131	CbGpPWpGaD
Procaine—Somnolence—Epirubicin—hematologic cancer	0.000113	0.000188	CcSEcCtD
Procaine—BCHE—Phospholipid metabolism—PIK3CG—hematologic cancer	0.000113	0.0013	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—FOXO1—hematologic cancer	0.000112	0.00129	CbGpPWpGaD
Procaine—Diarrhoea—Prednisone—hematologic cancer	0.000111	0.000185	CcSEcCtD
Procaine—Nausea—Betamethasone—hematologic cancer	0.000111	0.000185	CcSEcCtD
Procaine—Nausea—Dexamethasone—hematologic cancer	0.000111	0.000185	CcSEcCtD
Procaine—SCN10A—Axon guidance—IL6R—hematologic cancer	0.000111	0.00128	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—CREB1—hematologic cancer	0.000111	0.00128	CbGpPWpGaD
Procaine—Hypotension—Doxorubicin—hematologic cancer	0.00011	0.000183	CcSEcCtD
Procaine—Fatigue—Epirubicin—hematologic cancer	0.00011	0.000183	CcSEcCtD
Procaine—SCN10A—Developmental Biology—JAK1—hematologic cancer	0.00011	0.00126	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000109	0.00126	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—BRAF—hematologic cancer	0.000109	0.00126	CbGpPWpGaD
Procaine—Urticaria—Methotrexate—hematologic cancer	0.000108	0.00018	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—TNF—hematologic cancer	0.000108	0.00125	CbGpPWpGaD
Procaine—Dizziness—Prednisone—hematologic cancer	0.000108	0.000179	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000108	0.00124	CbGpPWpGaD
Procaine—Body temperature increased—Methotrexate—hematologic cancer	0.000108	0.000179	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000107	0.000179	CcSEcCtD
Procaine—BCHE—Metabolism—GMPS—hematologic cancer	0.000106	0.00122	CbGpPWpGaD
Procaine—BCHE—Metabolism—FTCD—hematologic cancer	0.000106	0.00122	CbGpPWpGaD
Procaine—BCHE—Metabolism—PHYH—hematologic cancer	0.000106	0.00122	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—RPLP1—hematologic cancer	0.000106	0.00122	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MAP2K1—hematologic cancer	0.000106	0.00122	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000106	0.00122	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000105	0.00121	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000105	0.00121	CbGpPWpGaD
Procaine—Somnolence—Doxorubicin—hematologic cancer	0.000105	0.000174	CcSEcCtD
Procaine—Vomiting—Prednisone—hematologic cancer	0.000104	0.000172	CcSEcCtD
Procaine—Rash—Prednisone—hematologic cancer	0.000103	0.000171	CcSEcCtD
Procaine—Dermatitis—Prednisone—hematologic cancer	0.000103	0.000171	CcSEcCtD
Procaine—Fatigue—Doxorubicin—hematologic cancer	0.000102	0.000169	CcSEcCtD
Procaine—Urticaria—Epirubicin—hematologic cancer	0.000101	0.000168	CcSEcCtD
Procaine—Body temperature increased—Epirubicin—hematologic cancer	0.000101	0.000168	CcSEcCtD
Procaine—Hypersensitivity—Methotrexate—hematologic cancer	0.0001	0.000167	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.0001	0.00115	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3CD—hematologic cancer	9.9e-05	0.00114	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	9.89e-05	0.00114	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCB1—hematologic cancer	9.88e-05	0.00114	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—TUBB2A—hematologic cancer	9.74e-05	0.00112	CbGpPWpGaD
Procaine—BCHE—Metabolism—SMPD3—hematologic cancer	9.7e-05	0.00112	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	9.68e-05	0.00112	CbGpPWpGaD
Procaine—Nausea—Prednisone—hematologic cancer	9.67e-05	0.000161	CcSEcCtD
Procaine—SCN10A—Axon guidance—JAK2—hematologic cancer	9.64e-05	0.00111	CbGpPWpGaD
Procaine—Pruritus—Methotrexate—hematologic cancer	9.63e-05	0.00016	CcSEcCtD
Procaine—Hypersensitivity—Epirubicin—hematologic cancer	9.38e-05	0.000156	CcSEcCtD
Procaine—Urticaria—Doxorubicin—hematologic cancer	9.36e-05	0.000156	CcSEcCtD
Procaine—BCHE—Phospholipid metabolism—PIK3R1—hematologic cancer	9.35e-05	0.00108	CbGpPWpGaD
Procaine—Body temperature increased—Doxorubicin—hematologic cancer	9.32e-05	0.000155	CcSEcCtD
Procaine—Diarrhoea—Methotrexate—hematologic cancer	9.31e-05	0.000155	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCC3—hematologic cancer	9.23e-05	0.00106	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MAPK14—hematologic cancer	9.2e-05	0.00106	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—MDM2—hematologic cancer	9.16e-05	0.00106	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MET—hematologic cancer	9.06e-05	0.00104	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CDK4—hematologic cancer	9.06e-05	0.00104	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	9.05e-05	0.00104	CbGpPWpGaD
Procaine—Pruritus—Epirubicin—hematologic cancer	9.01e-05	0.00015	CcSEcCtD
Procaine—Dizziness—Methotrexate—hematologic cancer	9e-05	0.00015	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	8.82e-05	0.00102	CbGpPWpGaD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	8.72e-05	0.00101	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NOTCH1—hematologic cancer	8.72e-05	0.00101	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL6—hematologic cancer	8.72e-05	0.00101	CbGpPWpGaD
Procaine—Diarrhoea—Epirubicin—hematologic cancer	8.72e-05	0.000145	CcSEcCtD
Procaine—Hypersensitivity—Doxorubicin—hematologic cancer	8.68e-05	0.000145	CcSEcCtD
Procaine—Vomiting—Methotrexate—hematologic cancer	8.65e-05	0.000144	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—MME—hematologic cancer	8.64e-05	0.000997	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3CB—hematologic cancer	8.63e-05	0.000996	CbGpPWpGaD
Procaine—Rash—Methotrexate—hematologic cancer	8.58e-05	0.000143	CcSEcCtD
Procaine—Dermatitis—Methotrexate—hematologic cancer	8.57e-05	0.000143	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—CMA1—hematologic cancer	8.55e-05	0.000986	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—SUMO1—hematologic cancer	8.55e-05	0.000986	CbGpPWpGaD
Procaine—BCHE—Metabolism—B3GAT1—hematologic cancer	8.48e-05	0.000978	CbGpPWpGaD
Procaine—BCHE—Metabolism—ASNS—hematologic cancer	8.48e-05	0.000978	CbGpPWpGaD
Procaine—BCHE—Metabolism—DCK—hematologic cancer	8.48e-05	0.000978	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.44e-05	0.000974	CbGpPWpGaD
Procaine—Dizziness—Epirubicin—hematologic cancer	8.42e-05	0.00014	CcSEcCtD
Procaine—SCN10A—Developmental Biology—PTPN11—hematologic cancer	8.38e-05	0.000966	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—SPHK1—hematologic cancer	8.36e-05	0.000965	CbGpPWpGaD
Procaine—Pruritus—Doxorubicin—hematologic cancer	8.34e-05	0.000139	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	8.29e-05	0.000956	CbGpPWpGaD
Procaine—BCHE—Neuronal System—PRKCG—hematologic cancer	8.25e-05	0.000951	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CREB1—hematologic cancer	8.12e-05	0.000936	CbGpPWpGaD
Procaine—Vomiting—Epirubicin—hematologic cancer	8.1e-05	0.000135	CcSEcCtD
Procaine—SLC6A3—Neuronal System—PRKCG—hematologic cancer	8.09e-05	0.000933	CbGpPWpGaD
Procaine—Nausea—Methotrexate—hematologic cancer	8.08e-05	0.000135	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—hematologic cancer	8.06e-05	0.000134	CcSEcCtD
Procaine—BCHE—Metabolism—HDC—hematologic cancer	8.04e-05	0.000927	CbGpPWpGaD
Procaine—Rash—Epirubicin—hematologic cancer	8.03e-05	0.000134	CcSEcCtD
Procaine—Dermatitis—Epirubicin—hematologic cancer	8.02e-05	0.000134	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—CREB1—hematologic cancer	7.97e-05	0.000919	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—NUP98—hematologic cancer	7.97e-05	0.000919	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6R—hematologic cancer	7.92e-05	0.000913	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CREBBP—hematologic cancer	7.91e-05	0.000912	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—BRAF—hematologic cancer	7.87e-05	0.000908	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—CREB1—hematologic cancer	7.82e-05	0.000902	CbGpPWpGaD
Procaine—Dizziness—Doxorubicin—hematologic cancer	7.79e-05	0.00013	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	7.74e-05	0.000892	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—BRAF—hematologic cancer	7.73e-05	0.000891	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—NUP214—hematologic cancer	7.68e-05	0.000886	CbGpPWpGaD
Procaine—Nausea—Epirubicin—hematologic cancer	7.57e-05	0.000126	CcSEcCtD
Procaine—SCN10A—Developmental Biology—MAP2K1—hematologic cancer	7.55e-05	0.00087	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.53e-05	0.000868	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	7.5e-05	0.000864	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—RPS14—hematologic cancer	7.49e-05	0.000864	CbGpPWpGaD
Procaine—Vomiting—Doxorubicin—hematologic cancer	7.49e-05	0.000125	CcSEcCtD
Procaine—BCHE—Phospholipid metabolism—PTEN—hematologic cancer	7.46e-05	0.00086	CbGpPWpGaD
Procaine—Rash—Doxorubicin—hematologic cancer	7.43e-05	0.000124	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—hematologic cancer	7.42e-05	0.000124	CcSEcCtD
Procaine—BCHE—Metabolism—CDA—hematologic cancer	7.35e-05	0.000848	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—SRC—hematologic cancer	7.34e-05	0.000846	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—FGF2—hematologic cancer	7.18e-05	0.000828	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—VEGFA—hematologic cancer	7.15e-05	0.000824	CbGpPWpGaD
Procaine—BCHE—Metabolism—PC—hematologic cancer	7.08e-05	0.000816	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—NRAS—hematologic cancer	7.06e-05	0.000814	CbGpPWpGaD
Procaine—Nausea—Doxorubicin—hematologic cancer	7e-05	0.000117	CcSEcCtD
Procaine—SCN10A—Developmental Biology—JAK2—hematologic cancer	6.88e-05	0.000794	CbGpPWpGaD
Procaine—BCHE—Metabolism—GBA—hematologic cancer	6.84e-05	0.000788	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC35B2—hematologic cancer	6.84e-05	0.000788	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MAPK3—hematologic cancer	6.76e-05	0.00078	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.71e-05	0.000774	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.6e-05	0.000761	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—MDM2—hematologic cancer	6.59e-05	0.00076	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.56e-05	0.000756	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—EIF4EBP1—hematologic cancer	6.55e-05	0.000755	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—MDM2—hematologic cancer	6.47e-05	0.000746	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTAP—hematologic cancer	6.25e-05	0.000721	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ALB—hematologic cancer	6.18e-05	0.000713	CbGpPWpGaD
Procaine—BCHE—Neuronal System—CREB1—hematologic cancer	6.11e-05	0.000704	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—KRAS—hematologic cancer	6.08e-05	0.000701	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—HSPA5—hematologic cancer	6.06e-05	0.000699	CbGpPWpGaD
Procaine—BCHE—Neuronal System—BRAF—hematologic cancer	6.03e-05	0.000695	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—CREB1—hematologic cancer	5.99e-05	0.000691	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—BRAF—hematologic cancer	5.92e-05	0.000683	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CALR—hematologic cancer	5.87e-05	0.000677	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—TGFB1—hematologic cancer	5.8e-05	0.000669	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—ALB—hematologic cancer	5.78e-05	0.000667	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—FBXW7—hematologic cancer	5.68e-05	0.000655	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.63e-05	0.000649	CbGpPWpGaD
Procaine—BCHE—Metabolism—FHL2—hematologic cancer	5.57e-05	0.000643	CbGpPWpGaD
Procaine—BCHE—Metabolism—AGRN—hematologic cancer	5.47e-05	0.00063	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EP300—hematologic cancer	5.39e-05	0.000621	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3CA—hematologic cancer	5.26e-05	0.000607	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SRC—hematologic cancer	5.24e-05	0.000604	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMMR—hematologic cancer	5.18e-05	0.000597	CbGpPWpGaD
Procaine—BCHE—Metabolism—IDH2—hematologic cancer	5.18e-05	0.000597	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—HRAS—hematologic cancer	5.17e-05	0.000596	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—VEGFA—hematologic cancer	5.1e-05	0.000588	CbGpPWpGaD
Procaine—BCHE—Neuronal System—MDM2—hematologic cancer	5.05e-05	0.000583	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—STAT3—hematologic cancer	5.05e-05	0.000582	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NRAS—hematologic cancer	5.04e-05	0.000581	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—HRAS—hematologic cancer	5.02e-05	0.000579	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—MDM2—hematologic cancer	4.96e-05	0.000572	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—IL6—hematologic cancer	4.94e-05	0.00057	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.89e-05	0.000563	CbGpPWpGaD
Procaine—BCHE—Metabolism—ARNTL—hematologic cancer	4.87e-05	0.000562	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MAPK3—hematologic cancer	4.83e-05	0.000557	CbGpPWpGaD
Procaine—BCHE—Metabolism—CA9—hematologic cancer	4.74e-05	0.000546	CbGpPWpGaD
Procaine—BCHE—Metabolism—ACP5—hematologic cancer	4.74e-05	0.000546	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.7e-05	0.000542	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TGFB1—hematologic cancer	4.68e-05	0.00054	CbGpPWpGaD
Procaine—BCHE—Metabolism—NCOR2—hematologic cancer	4.68e-05	0.000539	CbGpPWpGaD
Procaine—BCHE—Metabolism—IDH1—hematologic cancer	4.46e-05	0.000514	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCC3—hematologic cancer	4.41e-05	0.000508	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTO1—hematologic cancer	4.41e-05	0.000508	CbGpPWpGaD
Procaine—BCHE—Metabolism—TXN—hematologic cancer	4.41e-05	0.000508	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TNF—hematologic cancer	4.37e-05	0.000504	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—KRAS—hematologic cancer	4.34e-05	0.0005	CbGpPWpGaD
Procaine—BCHE—Metabolism—SPHK1—hematologic cancer	4.31e-05	0.000497	CbGpPWpGaD
Procaine—BCHE—Metabolism—UGT1A1—hematologic cancer	4.14e-05	0.000478	CbGpPWpGaD
Procaine—BCHE—Metabolism—CRABP1—hematologic cancer	4.03e-05	0.000465	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC22A1—hematologic cancer	4.03e-05	0.000465	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALOX5—hematologic cancer	3.93e-05	0.000453	CbGpPWpGaD
Procaine—BCHE—Metabolism—NUP98—hematologic cancer	3.8e-05	0.000439	CbGpPWpGaD
Procaine—BCHE—Metabolism—ADCY7—hematologic cancer	3.69e-05	0.000426	CbGpPWpGaD
Procaine—BCHE—Metabolism—NCOA3—hematologic cancer	3.69e-05	0.000426	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—HRAS—hematologic cancer	3.69e-05	0.000425	CbGpPWpGaD
Procaine—BCHE—Metabolism—NUP214—hematologic cancer	3.67e-05	0.000423	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.63e-05	0.000418	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.62e-05	0.000417	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTR—hematologic cancer	3.59e-05	0.000414	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCG2—hematologic cancer	3.59e-05	0.000414	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—HRAS—hematologic cancer	3.55e-05	0.00041	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6—hematologic cancer	3.53e-05	0.000407	CbGpPWpGaD
Procaine—BCHE—Metabolism—ENO2—hematologic cancer	3.52e-05	0.000406	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTT1—hematologic cancer	3.42e-05	0.000394	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.36e-05	0.000388	CbGpPWpGaD
Procaine—BCHE—Metabolism—SDC1—hematologic cancer	3.34e-05	0.000385	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—AKT1—hematologic cancer	3.26e-05	0.000375	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.19e-05	0.000368	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.15e-05	0.000363	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.14e-05	0.000362	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.01e-05	0.000347	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.94e-05	0.000339	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CCL2—hematologic cancer	2.92e-05	0.000337	CbGpPWpGaD
Procaine—BCHE—Metabolism—NQO1—hematologic cancer	2.84e-05	0.000327	CbGpPWpGaD
Procaine—BCHE—Metabolism—CD44—hematologic cancer	2.84e-05	0.000327	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.78e-05	0.000321	CbGpPWpGaD
Procaine—BCHE—Neuronal System—HRAS—hematologic cancer	2.77e-05	0.00032	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—HRAS—hematologic cancer	2.72e-05	0.000314	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYCS—hematologic cancer	2.69e-05	0.00031	CbGpPWpGaD
Procaine—BCHE—Metabolism—HSP90AA1—hematologic cancer	2.67e-05	0.000308	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.4e-05	0.000277	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTP1—hematologic cancer	2.37e-05	0.000273	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.29e-05	0.000264	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCB1—hematologic cancer	2.24e-05	0.000258	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTM1—hematologic cancer	2.18e-05	0.000251	CbGpPWpGaD
Procaine—BCHE—Metabolism—NCOR1—hematologic cancer	2.18e-05	0.000251	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTHFR—hematologic cancer	1.92e-05	0.000222	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.69e-05	0.000195	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CG—hematologic cancer	1.62e-05	0.000186	CbGpPWpGaD
Procaine—BCHE—Metabolism—CREBBP—hematologic cancer	1.5e-05	0.000173	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CD—hematologic cancer	1.42e-05	0.000164	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALB—hematologic cancer	1.4e-05	0.000162	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3R1—hematologic cancer	1.34e-05	0.000155	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CB—hematologic cancer	1.24e-05	0.000143	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTEN—hematologic cancer	1.07e-05	0.000123	CbGpPWpGaD
Procaine—BCHE—Metabolism—EP300—hematologic cancer	1.02e-05	0.000118	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CA—hematologic cancer	7.55e-06	8.7e-05	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKT1—hematologic cancer	6.16e-06	7.11e-05	CbGpPWpGaD
